Malignant Peripheral Nerve Sheath Tumor: molecular pathogenesis and current management considerations.
about
Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides.Updates on the diagnosis and treatment of intracranial nerve malignant peripheral nerve sheath tumorsMalignant peripheral nerve sheath tumor in neurobifromatosis type-1: two case reports.Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor.Huge intrathoracic malignant peripheral nerve sheath tumor in an adolescent with neurofibromatosis type 1.Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus.TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions.Neurofibromatosis type 1: a single center's experience in Korea.Malignant peripheral nerve sheath tumor of the vulva, an unusual differential diagnosis for vulvar mass.Malignant peripheral nerve sheath tumors of the head and neck: a case series and literature reviewOverexpression of cyclooxygenase-2 in malignant peripheral nerve sheath tumor and selective cyclooxygenase-2 inhibitor-induced apoptosis by activating caspases in human malignant peripheral nerve sheath tumor cells.Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benignWilms' tumor gene 1 (WT1) silencing inhibits proliferation of malignant peripheral nerve sheath tumor sNF96.2 cell line.Carbon Ion irradiation in the treatment of grossly incomplete or unresectable malignant peripheral nerve sheaths tumors: acute toxicity and preliminary outcomeGenomic and molecular characterization of malignant peripheral nerve sheath tumor identifies the IGF1R pathway as a primary target for treatment.A case of persistent foot pain in a neurofibromatosis type I patient.Oncogene Mutation Survey in MPNST Cell Lines Enhances the Dominant Role of Hyperactive Ras in NF1 Associated Pro-Survival and Malignancy.Malignant peripheral nerve sheath tumours of the spine: clinical manifestations, classification, treatment, and prognostic factorsTelomere maintenance mechanisms in malignant peripheral nerve sheath tumors: expression and prognostic relevanceSurvival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumorsBreast metastases from a malignant peripheral nerve sheath tumor of the kidney: An unusual presentation.Myoepithelioma within the carpal tunnel: a case report and review of the literature.Photothermal therapy improves the efficacy of a MEK inhibitor in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.A distal ileum malignant peripheral nerve sheath tumor causing intussusception in a patient in China: a case report.Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways.Comprehensive adipocytic and neurogenic tissue microarray analysis of NY-ESO-1 expression - a promising immunotherapy target in malignant peripheral nerve sheath tumor and liposarcoma.High grade malignant peripheral nerve sheath tumors: outcome of 62 patients with localized disease and review of the literature.Soft tissue tumors and common metastases of the oral cavity.Neurogenic tumors of soft tissue.Role of ultrasonography in detection of renal artery pseudoaneurysm caused by retroperitoneal malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1.Prospect and progress of oncolytic viruses for treating peripheral nerve sheath tumors.Malignant peripheral nerve cell sheath tumour of the upper lip: a rare case.Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.Primary paraspinal malignant peripheral nerve sheath tumor.A neurogenic tumor containing a low-grade malignant peripheral nerve sheath tumor (MPNST) component with loss of p16 expression and homozygous deletion of CDKN2A/p16: a case report showing progression from a neurofibroma to a high-grade MPNST.Evaluation of intratumoural heterogeneity on ¹⁸F-FDG PET/CT for characterization of peripheral nerve sheath tumours in neurofibromatosis type 1.Clinical and molecular prognostic predictors of malignant peripheral nerve sheath tumor.Vulvar sarcomas: Short guideline for histopathological recognition and clinical management. Part 2.Malignant triton tumors--complete surgical resection and adjuvant radiotherapy associated with improved survival.
P2860
Q30454570-6F5CB14A-B1A9-4725-9DCD-3847014CD4BEQ30454733-08B77624-EFB4-410B-A555-19025F5F127AQ30485989-888AE1F2-5CCE-4F17-803F-1F0F4A7B5493Q33739269-AF16CBA9-488E-47ED-8569-1318A4DB98C7Q33757551-4B90DEBC-8832-4DA6-9EE8-3000CB181977Q33894449-7CF655FD-7790-4EDF-96EE-55EC80281A2BQ34105259-D76A2655-0003-475A-B220-B15690515AE8Q34347843-BA532ABC-F35A-488F-8007-B9E5AB7E0E44Q34578589-26DABDA4-EFB0-4D64-9A7B-D12A3F832180Q34753968-29EF280D-6EA9-40FA-9AF9-6B9AA89199ADQ35091515-486B51D3-850B-49ED-9681-DEB415DEA2EEQ35288214-B1BF7445-6FE6-46E6-8F22-C8D07BE14AB4Q35489149-5B5110DA-58F5-49D8-AE61-81EF55E9969EQ35609587-4BEDA599-DC44-4FCA-A05D-219BAEF55C29Q35627023-D4DE436F-7F72-4A0C-A84F-AB6FC84A7088Q35726032-A98EB4A3-3074-4A3D-89D0-B982E0DF12C2Q35740953-01BBCEC5-9D8E-4424-819A-83F1C6373288Q35916391-7011C76B-DF84-406A-B4E1-94258B8EB4B0Q36010135-163719C2-C1EB-4BF5-8BC6-BAF9AAEACC44Q36544082-96C9A046-F249-45EF-A025-9819C4F0873AQ36596586-1DB5E973-99E4-46DB-BE35-57FE5AB142E1Q37094323-4752C21B-B890-42C3-8B9B-E97088515E44Q37356157-1B73D015-0873-4E20-8640-6D94314FC3EEQ37408543-11116EA0-6902-4B6F-8EEB-AA78E02E6D86Q37593776-508A3B70-9592-4436-9469-F2C9785188A6Q37616238-4DDC7252-C70D-426B-9AFA-3FA81496668AQ37687307-0B1D182F-F6A9-4C56-82CF-522C2972E9C9Q37838069-EB414DD8-BB1D-403F-AE58-62A4CE2FBB65Q37903914-A6AF4479-236B-4F11-88B6-CC54562A3D97Q37993923-C83F0DF9-E5AA-446D-83D3-7E9C920AB38BQ39699379-A33581DB-389D-4FD0-903E-DA3280270C53Q40465319-52FD7E73-7F6A-4614-8D92-536E783DDE3FQ40559304-FE03FDD0-7ED8-40B0-82DB-7CF921D68260Q41264048-10B47FE1-C7D0-4B35-A558-870A12E773DCQ41604963-566064AF-B0BC-4CCA-8F4C-1ED011093DADQ41645564-F4CDE721-1B61-41CC-B961-F62D85CD2372Q43435827-D99E8861-144C-4426-BB51-9B41B75010E5Q44354395-B9CBA011-8620-4484-937F-8B201941FEEFQ45011446-384D902F-E850-4DEC-871D-4457521D4B02Q45820151-66301687-E852-4827-80B2-19836EC54198
P2860
Malignant Peripheral Nerve Sheath Tumor: molecular pathogenesis and current management considerations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Malignant Peripheral Nerve She ...... ent management considerations.
@en
Malignant Peripheral Nerve She ...... ent management considerations.
@nl
type
label
Malignant Peripheral Nerve She ...... ent management considerations.
@en
Malignant Peripheral Nerve She ...... ent management considerations.
@nl
prefLabel
Malignant Peripheral Nerve She ...... ent management considerations.
@en
Malignant Peripheral Nerve She ...... ent management considerations.
@nl
P2093
P2860
P356
P1476
Malignant Peripheral Nerve She ...... ent management considerations.
@en
P2093
Amir Shahlaee
Charles H Bush
John D Reith
Stephen R Grobmyer
Steven N Hochwald
P2860
P304
P356
10.1002/JSO.20971
P577
2008-03-01T00:00:00Z